Back to Search Results

Study Complete

Sponsor ID

20040210

Observational Safety Study of Etanercept (Enbrel) for Treatment of Psoriasis

Sponsor ID

20040210

Clinicaltrials.gov ID

EUCTIS ID

N/A

EudraCT ID

N/A

Study Details

This is an observational safety study tracking psoriasis patients on etanercept (Enbrel) for 5 years.

Additional Study Details

Phase

N/A

Product

etanercept

Type

Observational

Masking

N/A

Enrollment

2511

Additional Study Details

Protocol Summary

Primary Outcome Measures

Assess long-term safety of participating subjects, determine incidence rates of Serious Adverse Events (SAEs) and Serious Infectious Events (SIEs)

Timeframe: 5 years

Secondary Outcome Measures

Patient- and physician- reported outcomes and healthcare resource use over time

Timeframe: 5 years

Whether rates of SAEs, SIEs, and EMIs differ according to (a) prior exposure to systemic therapies or phototherapy, (b) exposure to Enbrel therapy, and (c) presence of certain co-morbid disorders

Timeframe: 5 years

Evaluate incidence rates of Events of Medical Interests (EMIs) for participating subjects

Timeframe: 5 years

Study Documents

Study Synopsis

Available Language(s): English

Download Document(s)

Locations

No locations found.